Why Attend
Over the past five years, WHIS has become the #1 annual event that connects the industry-leading stakeholders in women’s health. We unite pharmaceutical companies, investors, medical devices companies, biotechs, startups, femtech, payers, researchers,HCPs, consultants, and beyond, looking to drive innovation at the convergence of healthcare and technology.
As the industry collectively continues to work towards improving health outcomes for women, we’re expanding our focus to include more government representatives, policymakers, and NPOs as we steer the conversation towards advocacy, access, and action in line with industry needs.
With more opportunities than ever before, we’re delighted to welcome you.
2023 SERIES ADVISORY BOARD
Alice Zheng
Elizabeth Garner
Jamie White
Kalahn Taylor-Clark
Valerie Palmieri
Sandy Milligan
Lucy Perez
Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.
Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America. She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.
Dr. Neel Shah
Raymon uit de Bulten
Rachel Braun Scherl
Bethany Corbin
Anula Jayasuriya
2023 Innovation Showcase
The Innovation Showcase is a unique opportunity for emerging companies with a disruptive technology, product, or service to present in front of the industry’s most influential partners, investors, and decision makers.
Split across two days and focused on early-stage funding and later-stage funding, 24 start-up finalists, hand-picked by our Selection Committee, will spotlight their innovation, highlight their achievements, and gain industry exposure.
This year, we’re introducing prize bundles for the two winners, as well as an intimate drinks reception for all applicants who attend the summit.
Applications close July 7
PLEASE NOTE: IF YOU ARE A SUCCESSFUL FINALIST, A TICKET MUST BE PURCHASED TO ATTEND THE SUMMIT
Academic Poster Session: Verticals that Differently or Predominantly Affect Women
Apply to showcase your innovative research that focus on verticals that differently or predominantly affect women’s health. During this session, 5 academic posters will be displayed to our audience of potential partners, funders, and accelerators.
2022 Testimonials & Success Stories
Attendee Breakdown
2023 Partners
Innovation Partner
Organon
Website: https://www.organon.com/
Organon (NYSE: OGN) is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets. Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, N.J.
Oncology Partner
GSK
Website: https://www.gsk.com/en-gb/
GSK is focused on maximising patient survival through transformational medicines. Our oncology pipeline is focused on immuno-oncology, cell therapy, tumour cell targeting therapies and synthetic lethality. Our goal is to achieve a sustainable flow of new treatments based on a diversified portfolio of investigational medicines.
Gynaecologic cancers are among the most common cancers affecting women. Nearly 1.4 million people were diagnosed with cervical, endometrial, ovarian, vaginal or vulvar cancer in 2020; however, awareness of these cancers and their symptoms remains low. At GSK, we are committed to supporting continued innovation in gynaecologic cancers, keeping the patient’s voice at the heart of our mission, and building a pipeline of novel programmes to meet their needs. For more information about our work in oncology, please visit: https://www.gsk.com/en-gb/
Knowledge Partner
McKinsey and Company
Website: https://www.mckinsey.com/
There was a time when economic growth, sustainability, and inclusion were seen as trade-offs, but leaders today need to achieve all three. This new paradigm of growth will be more sustainable, driving innovation while reducing environmental impact. It will also be more inclusive, creating access to opportunities for people worldwide.
This is not an easy task, but McKinsey & Company's ambition is to help organizations and their leaders make it a reality. They combine bold strategies and transformative technologies to help organizations innovate more sustainably, achieve lasting gains in performance, and build workforces that will thrive for this generation and the next.
Platinum Partner
Myovant
Website: https://www.myovant.com/
We aspire to redefine care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy.
Our purpose is resolute and fueled by the opportunity to improve the lives of millions of women and men, many impacted by diseases during their most productive years of life. Despite the significant burden of common diseases like uterine fibroids, endometriosis, and prostate cancer, many women and men do not have the options they deserve and need.
Deloitte
Website: www.deloitte.com
Where impact happens
Throughout the health ecosystem, you’ll find courageous and inspiring people who are committed to driving transformation, advancing health equity, and leading a well-being revolution. Where you find innovators committed to sustainable progress, you’ll find Deloitte’s Life Sciences & Health Care practice. Our leaders work side by side to orchestrate and deliver on the business of science and health. We bring trusted, flexible approaches that can foster innovation, harness new technologies, and formulate consumer-driven strategies to engineer a digitally enabled, equitable future of health—starting today.
Gold Partners
Watkins-Conti Products Inc
Website: http://www.watkinscontiproducts.com/
Watkins Conti Products, Inc. is a Female founded and owned, Platform Women’s Healthcare company and product design firm that is focused on the creation of innovative and affordable consumer medical devices.
The company’s flagship product is a non-invasive solution for stress incontinence in women. The problem impacts and estimated ONE in THREE women globally. The disruptive, patented product offers multiple recurring revenue streams. Watkins-Conti has additional products in the pipeline to improve the consumer experience, specifically for health related issues that women face that are often seen as shameful or taboo.
Celanese
Website: https://bit.ly/3a0JriQ
Celanese works closely with you as a strategic partner to create innovative controlled-release dosage forms for biologics and small molecules to meet the goals of patient-centric therapies, improved medicine and better healthcare economics. Our VitalDose® EVA copolymer drug-delivery platform is an enabling technology for drug-eluting implants, inserts and transdermal films. The platform is flexible and customizable to address a variety of formulation challenges when it comes to tailoring the release rate of your drug.
- Compatible with biologics and small molecules
- Provides reliable local or systemic drug administration
- High drug loading capacity (≤ 75%)
- Engineered long-acting dosage profiles (zero-order or nonlinear profiles)
- Ease of formulation and configurable into a variety of geometries
- An established regulatory path with long clinical use history
From FEASIBILITY to DEVELOPMENT to COMMERCIALIZATION
Our scientists and engineers are there from concept to commercialization, providing development services, material supply aligned with GMP principles and regulatory support.
PRIA Healthcare
Website: https://priahealthcare.com/who-we-help/medical-device-manufacturers/
PRIA Healthcare provides patient solutions for medical device reimbursement. We believe patients deserve to have access to—and insurance coverage for—the most innovative and scientifically proven medical devices, treatments, and procedures so they can receive the care their health and well-being depend on.
At the Reproductive Health Innovation Summit, industry veterans and experts from PRIA Healthcare will discuss the importance of early consultative involvement for innovative treatments and navigation in the strategic reimbursement landscape, as well as market and patient access solutions. Join us for an enlightening discussion around how to drive maximum adoption of your therapy from conception to patient access to ensure progressive treatments in the reproductive health arena are accelerated to their full potential.
UPMC
Website: http://www.upmc.com/
A $26 billion health care provider and insurer, Pittsburgh-based UPMC is inventing new models of patient-centered, cost-effective, accountable care. The largest nongovernmental employer in Pennsylvania, UPMC integrates 95,000 employees, 40 hospitals, 800 doctors’ offices and outpatient sites, and a nearly 4.5 million-member Insurance Services Division, the largest medical insurer in western Pennsylvania. In the most recent fiscal year, UPMC contributed $1.5 billion in benefits to its communities, including more care to the region’s most vulnerable citizens than any other health care institution, and paid more than $900 million in federal, state, and local taxes. Working in close collaboration with the University of Pittsburgh Schools of the Health Sciences, UPMC shares its clinical, managerial, and technological skills worldwide through its innovation and commercialization arm, UPMC Enterprises, and through UPMC International. U.S. News consistently ranks UPMC Presbyterian Shadyside among the nation’s best hospitals in many specialties and ranks UPMC Children’s Hospital of Pittsburgh on its Honor Roll of America’s Best Children’s Hospitals. For more information, go to UPMC.com.
PPD
Website: https://www.ppd.com/
PPD is a leading global contract research organization focused on delivering life-changing therapies. PPD offers proven solutions that incorporate diversity in every stage of the clinical trial ranging from early phase engagement with lactation studies to Phase II-III to pharmacovigilance to peri- and post-approval services and vaccines.
PPD has a deep understanding of the regulatory drivers, treatment landscape, unmet needs and recruitment and retention strategies across the spectrum of women’s health indications. We are committed to deploying solutions needed to mitigate potential challenges in women’s health studies, including competition for women in clinical trials and site resources, and the reluctance of women to participate in these studies. We leverage our broad-based site network, targeted training and communication strategies – all with women in mind.
Clinical Trial Site and Patient Centric Solutions | PPD
EDS Global Capabilities | PPD Inc
Labcorp
Website: www.Labcorp.com
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. Learn more about Labcorp at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.
PFG MedComm
Website: www.pfgmed.com/
Accomplishing access through value communication. That’s what we do.
PFG MedComm is a woman and minority-owned strategic market access agency that specializes in leveraging value communication to achieve access goals. We’ve transformed the traditional agency model with our unique 360° approach that considers the entire development lifecycle when planning for market access. Our proprietary process involves anticipating challenges, adapting strategic plans, and accomplishing access through seamless execution and field engagement.
As a full-service strategic market access agency, our capabilities run the gamut from the earliest stages of clinical planning and strategy through launch, training and beyond. We are experts in developing end-to-end marketing strategies and tactics across all healthcare stakeholders, (ranging from various types of payers and access decisionmakers to healthcare professionals and patients), with experience in US and international markets across EMEA, LATAM and APAC.
Our team has a broad range of experience to support medical, payer and HEOR communication strategy across pharmaceutical, biotech, medical device, and digital therapeutic companies. Over the past ten years, the PFG MedComm team has supported over 60+ brands (including 33 launches both US and global), across 50+ indications within 20+ therapeutic categories.
We take those complicated ideas and make them understandable to all stakeholders to ensure a company's drugs, therapies, devices, and diagnostics reach those who need them with minimal hurdles.
Event Partners
Bowdoin Group
Website: www.bowdoingroup.com/
The Bowdoin Group specializes in executive search, focused on placing change-makers and strategic leaders across the innovation economy while supporting additional growth through recruitment process outsourcing (RPO).
Our network covers the Health and Technology industries, placing disruptive leaders who are redefining the landscape of how we live and work.
Within the Health and Technology landscape, the firm’s expertise in Digital Health, Software and Technology, FinTech, Biotech, and Diagnostics inform the service we provide for our clients and partners leading these industries. We continue to build lasting partnerships across the financial sector, building out portfolio companies for top-tier Private Equity and Venture Capital firms.
Restful Pump
Website: https://restfulpump.com/
Founded by a mom for moms, Restful Pump® has engineered the world’s first to market premier forward leaning lactation systems for at home, at work or on the go.
Postpartum women are fatigued, sleep deprived, managing breast pumping positioning, milk supply issues, pain and/or breast tissue complications, and some addressing return to employment. Using a breast pump every 4-5 hours, 24 hours a day doesn’t have to be such an uncomfortable chore.
Now women can rest, sleep, or multitask in a supportive hands-free position, using any type of breast pump. While providing comfort, convenience, productivity, possibly reducing breast tissue complications and increasing pumping durations, our devices may even negate the need for baby formula.
Restful Pump® is solving a global problem with novel Class 1 medical devices. With an MD’s prescription, and possible US reimbursement via health insurance, Restful Pump® products aim to be as medically necessary as a breast pump in the postpartum period.
With over 12 patents filed for over 10 products in 30 countries there is massive potential for safe, high-yield investments with durable medical equipment annual recurring revenue.
Pump While You Sleep®
Sheppard Mullin
Website: www.sheppardmullin.com/whlc
Sheppard Mullin’s Women in Healthcare Leadership Collaborative (WHLC) is an exclusive national leadership initiative committed to supporting women professionals in or advancing into leadership positions within the healthcare and life sciences industries.
WHLC was established in response to significant and persistent systemic gender disparities in institutional leadership positions in the healthcare and life sciences industries. Despite constituting a vast majority of the workforce, women continue to hold a small minority of these positions.
Drawing upon Sheppard Mullin’s nationally-ranked healthcare practice, and the law firm’s leadership in diversity and inclusion, WHLC aims to reverse this trend by providing women professionals access to critical resources and networking opportunities designed to support them as they progress in their careers. WHLC hosts regular roundtable discussions focusing on complex legal and business issues and cutting-edge innovation and developments in the healthcare industry, as well as professional skills training and development, and quality networking events connecting these professionals to other leaders in the industry. Sheppard Mullin hosts WHLC events virtually and in various locations across the country.
Event & Media Partner
Boston Globe Media
Website: https://www.bostonglobe.com/
Boston Globe Media is a multimedia organization that provides news, entertainment, and commentary across multiple brands and platforms.
Through in-depth reporting and coverage coming straight from the world’s hub of innovation in health, science, and medicine, Boston Globe Media gives brands the opportunity to create meaningful content, align themselves with award-winning journalism, and reach a robust audience of readers keenly focused on advancements in healthcare and beyond. With powerful storytelling, in-depth filmmaking, great advice, interactive local and global events, immersive branded content, and the largest social media following in New England, we go beyond advertising and help brands forge a meaningful connection with the audiences they want to reach. If you want to educate, entertain, or simply introduce your brand to the world, then allow us to reintroduce ourselves. We are Boston Globe Media.
Read, listen and discover more at Globe.com, Boston.com, STAT, Globe Events, and our in-house creative agency, Studio/B.
Media Partners
Women of Wearables
Website: https://www.womenofwearables.com/
Please visit our website for more information.Femtech World
Website: https://www.femtechworld.co.uk/
We are a global media platform, run by award winning journalists, on a mission to contribute to closing the gender health gap by providing valuable news, insights and analysis on the exciting femtech sector. Produced by specialist health media group Aspect Publishing, Femtech World aims to give the femtech community a voice, breaking down professional borders, spreading opportunities and destigmatising women’s health issues.
Springboard
Website: https://sb.co
Springboard’s mission is to accelerate the growth of entrepreneurial companies led by women through access to essential resources and a global community of experts. We are a leading network of influencers, investors and innovators dedicated to building high-growth companies led by women who are transforming industries in technology and life science.
World Pharma Today
Website: https://www.worldpharmatoday.com/
Please visit our website for more information.Pharma News HQ
Website: http://pharmanewshq.com/
Pharma News HQ, the journal dedicated to the pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmanewshq.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production
MassMEDIC
Website: http://www.massmedic.com/
Founded in 1996, the Massachusetts Medical Device Industry Council (MassMEDIC) is the largest regional medtech association in the United States, with over 300 members representing manufacturers, product developers, suppliers, research institutions and academic health centers.
For more than a quarter of a century, MassMEDIC has been the voice of the groundbreaking medical technology industry in New England, advocating for sound public policy that supports innovation and fostering a community built on a shared purpose.
As a MassMEDIC member, you are part of a community of innovators that believe in collaboration and collective success. Our network and resources help you navigate today’s evolving healthcare ecosystem and strengthen your goals through connection, education, awareness, and advocacy.
Magee-Womens Research Institute
Website: https://mageewomens.org/
Please visit our website for more information.2023 Speakers
Kevin Ali
Carolee Lee
Carolee Lee is an innovator, entrepreneur and thought leader dedicated to improving women’s health and wellbeing, and their opportunities to succeed. She was founder and CEO of Carolee Designs, one of the world’s leading accessories brands. Carolee launched WHAM (Women’s Health Access Matters), a nonprofit organization working to bring awareness and funding to women’s health research to transform women’s lives. Carolee forged a research partnership with the RAND Corporation to create The WHAM Report, the first study to analyze the economic costs, benefits and social impacts of health research that focuses specifically on women. The WHAM Report is changing the conversation around women’s health research, proving women’s health research is an economic issue we cannot afford to ignore. Through partnerships with leading advocacy groups, business leaders, researchers and economists, WHAM is using this data drive change.
Carolee is also a mentor and leader in business, philanthropic and educational organizations. She is a past Chair and Foundation Board Chair of the Committee of 200, a community of the most successful women in business, and has served as director on the board of DSW, Inc. Carolee is a founding board member of The Breast Cancer Research Foundation, where she has served since 1986. She currently sits on the Women’s Leadership Board at The John F. Kennedy School of Government at Harvard University.
Alice Zheng, MD, MBA, MPH
Allison Watkins-Conti
Chris Pagano
Dora Hughes
Tami L Wahl
Gail Maderis
Sandy Milligan, MD, JD
Lucy Perez
Lucy is a Senior Partner in McKinsey’s Boston office. Lucy has 15+ years of experience advising CEOs and top teams at leading pharma, biotech and life sciences companies globally on growth strategy, innovation, sustainability, and organizational transformation.
Lucy co-leads McKinsey’s ESG domain and McKinsey’s All-In DEI efforts in North America. She also sponsors the Hispanic Latino Network at McKinsey and leads our research efforts on health equity.
Laura Veroneau
Rachel Robinson
Katie Schubert
Diana Contreras
Libby Greer,
Shakun Sethi
Anna Daily
Brian Wilson
Gurjeet Singh
Katie Capanna
Audrey Sheppard
Suzanne Steinbaum
Michael Annichine
Ru-fong Cheng
Candace Tingen
Bethany Corbin
Elizabeth Garner
Elizabeth Garner is Chief Medical Officer at ObsEva, a Swiss women’s health specialty pharmaceutical company headquartered in Geneva. With over a decade of experience in the pharmaceutical industry, Dr. Garner has wide expertise in drug development, including clinical trial design and conduct, regulatory and FDA Advisory Committee strategy, support of commercial launch planning, medical affairs, and pharmacovigilance. As a member of ObsEva’s Executive Committee, she provides strategic leadership on the Company’s overall development strategy and frequently represents ObsEva to investor, Key Opinion Leader (KOL), and other key stakeholders.
From 2014 to 2019, Dr. Garner was Chief Medical Officer of Agile Therapeutics, located in Princeton, NJ. She played a crucial role during Agile’s 2014 Initial Public Offering and was instrumental in the Company’s Investor Relations, Communications, and Business Development strategies. Dr. Garner led the clinical development of Twirla®, Agile’s low-dose contraceptive patch, took the Company through an FDA dispute resolution process, and was the presenter and moderator for Agile’s successful FDA Advisory Committee meeting in October 2019, which led to FDA approval of Twirla® in February, 2020. She also led pre-launch activities, including commercial support, medical affairs, KOL development, and the pharmacovigilance and Medical Information programs.
Prior to her position at Agile, Dr. Garner was Vice President of Medical Affairs, Preventive Care at Myriad Genetics, where she managed the women’s health research, publication, and KOL development programs, provided medical and scientific input on Myriad’s marketing and new product strategies, served as its media spokesperson, and directed an experienced team of Field Medical Specialists. Before that, she was Senior Director at Abbott Laboratories, where she oversaw all clinical aspects of the global Phase 3 endometriosis development program for elagolix, which was FDA-approved in 2018.
From 2007 to 2011, Dr. Garner was Associate Director then Director of Clinical Research at Merck Research Laboratories. As a leader on the human papillomavirus (HPV) vaccine program she was instrumental in achieving successful outcomes on important regulatory submissions. Dr. Garner also served as chair of the Gardasil®9 HPV vaccine program Product Development Team, leading scientific, regulatory, global access and medical affairs strategies. Dr. Garner was the presenter and moderator for the successful 2010 FDA Gardasil® Advisory Committee Meeting. She also had substantial involvement in commercialization strategy and KOL development, and participated in due diligence on infectious disease and women’s health products.
Dr. Garner received joint M.D. and M.P.H degrees from Harvard Medical School and Harvard School of Public Health. She was trained in obstetrics and gynecology at Brigham and Women’s/Massachusetts General Hospitals and completed a fellowship in gynecologic oncology at Brigham and Women’s/Dana Farber Cancer Institute. Prior to entering the pharmaceutical industry, Dr. Garner focused on academic clinical practice, basic science research in ovarian cancer, and teaching and mentorship of fellows, residents, and medical students at Harvard Medical School. She is an author on numerous peer-reviewed scientific papers.
Dr. Garner is a member of the Board of Directors of Kezar Life Sciences, a publicly traded company focused on the development of new therapies targeting protein homeostasis for the treatment of autoimmune diseases and cancer. She serves on the board’s audit and clinical strategy & execution committees. She is also on the Board of Directors of the Drug Information Association (DIA), a member-driven volunteer organization for global healthcare product development; she serves on the audit committee. She is on the Board of Directors and is Chair of the finance committee of the American Medical Women’s Association, a professional organization which functions at the local, national, and international level to advance women in medicine. Dr. Garner also serves on the Board of the Executive Women of New Jersey and was a 2018 honoree at its Salute to the Policy Makers gala, which recognizes executive women leaders across all industries. She is also on the Board of CorStone, a global non-profit organization focused on resilience in youth. Dr. Garner was a 2019 awardee of the PharmaVoice 100 Most Inspiring Individuals in the life sciences industry.
Terry Weber
Linda Goler Blount
Liz Powell
Mimi Ghosh
Primavera Spagnolo, MD, PhD
Dr. Neel Shah
Elizabeth Cherot
Jacqueline Oliveria-Cella
Sarah Ahmad
Bethany Young Holt
Abigail Sirus
Traci Keen
Brian Levine
Sonia Gupta
Rachel Braun Scherl
Joanne Armstrong
Kerry Rupp
Sandy Milligan
Sheena Gill
Golnoush Golshirazi
Oriana Papin-Zoghbi
Lisa Tate
Bilikis Oladimeji
Crystal Tyler
Laine Bruzek
Elizabeth Bailey
Lisa Rohan
Amy Meister
Nada Hanafi
View the 2023 agenda
Please fill in your details on the right-hand side to access the conference agenda.
What’s on offer at the biggest industry-led women’s health event?
- 50+ World Class Industry Speakers
- 3 Content Tracks Covering Business Development, Research & Development and Advocacy
- 750+ C-Level Executive Attendees All Under One Roof
- Workshop Pre-Day
- Multiple VIP Forums and Intimate Roundtables
- Unlimited Networking Time
View the 2023 agenda
REGISTRATION
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Ticket price will increase after
— June 30, 2023 —
Venue
The Westin Copley Place, Boston, 10 Huntington Avenue, Boston, MA, 02116
Step into a AAA Four-Diamond hotel in downtown Boston's celebrated Back Bay area - a short stroll from fine dining destinations and upscale clothing stores in the popular Copley Place shopping mall. The Westin Copley Place, Boston welcomes guests with modern hotel accommodations and signature touches.
Boston Symphony Hall, Fenway Park and other downtown attractions are within easy reach of our hotel. In the evening, retreat to beautifully appointed hotel rooms and suites featuring stylish decor, the plush Westin Heavenly® Bed and spacious bathrooms.
Book your room!
Reserve your room using our preferential room rate here.
($355 + tax per night).
Partner with Us
Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.
To discuss your objectives and partnership opportunities please contact [email protected]
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]
Returning Safely Measures
Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.
All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.
Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.
